Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
Organogenesis Holdings (ORGO) Stock Price & Analysis
389 Followers
ORGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.96 - $4.71
Previous Close$2.79
Volume547.96K
Average Volume (3M)1.20M
Market Cap
$369.88M
Enterprise Value$365.02M
Total Cash (Recent Filing)$103.84M
Total Debt (Recent Filing)$98.98M
Price to Earnings (P/E)64.3
Beta1.03
Next Earnings
Aug 07, 2024EPS Estimate
<$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding132,572,465
10 Day Avg. Volume1,009,278
30 Day Avg. Volume1,195,961
Standard Deviation0.24
R-Squared0.13
Alpha-0.00944
Financial Highlights & Ratios
Price to Book (P/B)1.42
Price to Sales (P/S)0.77
Price to Cash Flow (P/CF)7.80
P/FCF Ratio10.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.84
Enterprise Value/Gross Profit1.12
Enterprise Value/Ebitda13.00
Forecast
1Y Price Target
$4.67Price Target Upside67.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Organogenesis Holdings News
PremiumCompany Announcements
Organogenesis Shareholders Affirm Governance and Strategy
Bulls Say, Bears Say
Bulls Say
Clinical TrialsThe trial achieved its primary endpoints showing a statistically significant reduction in knee pain and maintenance of function at 6 months.
Market PotentialReNu could take share in the ~$1B market from current SOC, Hyaluronic Acid (HA), in a market consisting of 2M – 2.4M procedures annually.
Product StabilityPuraPly is finally stable across the entire product family, suggesting ORGO is stabilizing pricing.
Bears Say
Competitor PerformanceCompetitor Smith & Nephew's product Grafix is experiencing significant price declines, down 30.2% quarter-over-quarter and 67.4% year-over-year.
Market ImpactShares suffered a setback from the result of a proposed LCD impacting the Advanced Wound Care market.
Pricing PressureAffinity saw a price decrease of 13.9% quarter-over-quarter, with year-over-year pricing down 26%.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ORGO FAQ
What was Organogenesis Holdings Inc’s price range in the past 12 months?
Organogenesis Holdings Inc lowest stock price was $1.96 and its highest was $4.71 in the past 12 months.
What is Organogenesis Holdings Inc’s market cap?
Currently, no data Available
When is Organogenesis Holdings Inc’s upcoming earnings report date?
Organogenesis Holdings Inc’s upcoming earnings report date is Aug 07, 2024 which is in 32 days.
How were Organogenesis Holdings Inc’s earnings last quarter?
Organogenesis Holdings Inc released its earnings results on May 09, 2024. The company reported -$0.015 earnings per share for the quarter, beating the consensus estimate of -$0.023 by $0.008.
Is Organogenesis Holdings Inc overvalued?
According to Wall Street analysts Organogenesis Holdings Inc’s price is currently Undervalued.
Does Organogenesis Holdings Inc pay dividends?
Organogenesis Holdings Inc does not currently pay dividends.
What is Organogenesis Holdings Inc’s EPS estimate?
Organogenesis Holdings Inc’s EPS estimate is <$0.01.
How many shares outstanding does Organogenesis Holdings Inc have?
Organogenesis Holdings Inc has 132,572,460 shares outstanding.
What happened to Organogenesis Holdings Inc’s price movement after its last earnings report?
Organogenesis Holdings Inc reported an EPS of -$0.015 in its last earnings report, beating expectations of -$0.023. Following the earnings report the stock price went up 32.895%.
Which hedge fund is a major shareholder of Organogenesis Holdings Inc?
Among the largest hedge funds holding Organogenesis Holdings Inc’s share is Caxton Associates LP. It holds Organogenesis Holdings Inc’s shares valued at 88K.
---
Organogenesis Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.67 (67.99% Upside)
$4.67 (67.99% Upside)
Blogger Sentiment
Bullish
ORGO Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 31.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.71%
12-Months-Change
Fundamentals
Return on Equity
2.15%
Trailing 12-Months
Asset Growth
2.77%
Trailing 12-Months
Company Description
Organogenesis Holdings Inc
Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
---
ORGO Earnings Call
Q1 2024
0:00 / 0:00
---
ORGO Stock 12 Month Forecast
Average Price Target
$4.67
▲(67.99% Upside)
Technical Analysis
Best Analysts Covering ORGO
1 Year
1 Year Success Rate
13/32 ratings generated profit
1 Year Average Return
+44.34%
reiterated a buy rating 2 months ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 40.63% of your transactions generating a profit, with an average return of +44.34% per trade.
---